Interim results of an open-label study to assess the effects of delayed-release dimethyl fumarate on lymphocyte subsets and immunoglobulins in patients with relapsing-remitting multiple sclerosis

Authors
Category Primary study
JournalNeurology
Year 2017
This article has no abstract
Epistemonikos ID: 2e58a7443fd38f029f45693ef1c8b16af5802c31
First added on: Feb 08, 2025